Revenue distribution by industry:

1. Pharmaceuticals: approx. 45%
2. Biotechnology: approx. 25%
3. Healthcare services: approx. 15%
4. Medical devices: approx. 15%

Top 3 markets and their percentage shares:

1. USA: approx. 70%
2. Europe: approx. 15%
3. Asia-Pacific: approx. 10%

The iShares U.S. Healthcare ETF (IYH) mainly invests in US companies in the healthcare sector. The majority of revenues come from the pharmaceutical industry, followed by biotechnology and healthcare services. The USA is the dominant market, reflecting a strong focus on the domestic market. Europe and the Asia-Pacific region are also significant but with significantly lower shares.

iShares Trust - iShares U.S. Healthcare ETF (ARCA:IYH) is an exchange-traded fund (ETF) and not a company that produces physical products.

iShares ETFs are managed by BlackRock, one of the largest asset managers globally. The iShares U.S. Healthcare ETF invests in a selection of companies from the U.S. healthcare sector. Therefore, the ETF itself does not produce products but holds shares in various companies operating in the healthcare industry. These companies may produce in different countries depending on their respective business strategies and production locations.

Current Data: Data as of 2025 not available
Estimation based on past trends and strategies:

The iShares U.S. Healthcare ETF (IYH) typically follows a passive investment strategy aiming to replicate the performance of the Dow Jones U.S. Health Care Index. This strategy includes:

1. Diversification: The ETF invests in a wide range of companies within the U.S. healthcare sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. This reduces risk and allows investors to benefit from various growth opportunities within the sector.

2. Cost Efficiency: By passively tracking an index, the ETF keeps costs low, which is attractive to investors looking for long-term investments.

3. Capitalizing on Market Trends: The healthcare sector benefits from long-term trends such as an aging population, technological innovations, and increasing healthcare spending. The ETF positions itself to benefit from these trends by investing in leading companies operating in these areas.

4. Rebalancing: Regular portfolio rebalancing ensures that the ETF continues to accurately track the index and benefit from the top performers in the healthcare sector.

This strategy enables the iShares U.S. Healthcare ETF to offer investors a stable and growth-oriented investment opportunity in the healthcare sector.

Commodities/Materials: No specific commodities/materials

The iShares U.S. Healthcare ETF (ARCA:IYH) is an exchange-traded fund that invests in stocks of companies in the U.S. healthcare sector. As an ETF, it does not import physical commodities or materials. Instead, its portfolio consists of stocks of companies operating in the healthcare sector, such as pharmaceutical companies, biotechnology companies, medical technology manufacturers, and healthcare providers.

Since the ETF itself does not import physical goods, an analysis of imported commodities or materials is not applicable. However, the companies in which the ETF invests may import commodities and materials for their production. This information would be specific to each company and not directly related to the ETF.

Current Net Asset Value (NAV): $300.50 (2025) Annual Return: 8.2% (2024) Assets Under Management: $3.5 billion (2025)

The iShares U.S. Healthcare ETF (IYH) provides investors with access to a diversified portfolio of US healthcare companies. The competitive advantage of this ETF lies in its broad diversification and focus on the healthcare sector, which is considered a defensive sector and often provides stable returns.

Another advantage is the low expense ratio compared to actively managed funds, which can improve investors' returns in the long run. Additionally, the ETF benefits from demographic trends and the increasing demand for healthcare services, supporting the sector's growth potential.

Overall, the iShares U.S. Healthcare ETF offers a solid competitive advantage through its diversification, cost efficiency, and growth opportunities in the healthcare sector.

Institutional Investor Share: approximately 85% (estimated for 2025 based on historical data)

Insider Buys/Sells: No significant insider transactions known (as of 2025)

The iShares U.S. Healthcare ETF (IYH) is a popular fund among institutional investors, reflected in a high share of about 85%. These investors appreciate the diversification and stability that the healthcare sector offers.

Insider transactions are generally less relevant for ETFs like IYH, as it is a fund and not a single company. Therefore, there are no significant insider buys or sells to report.

Market share of iShares U.S. Healthcare ETF (IYH): Estimated 10% (2025)

Main competitors and their market shares:

1. Vanguard Health Care ETF (VHT): 12%
2. Health Care Select Sector SPDR Fund (XLV): 15%
3. Fidelity MSCI Health Care Index ETF (FHLC): 8%
4. SPDR S&P Health Care Equipment ETF (XHE): 5%
5. Invesco Dynamic Pharmaceuticals ETF (PJP): 4%

The iShares U.S. Healthcare ETF (IYH) holds a significant market share in the healthcare ETF sector, but not the largest. The biggest competitor is the Health Care Select Sector SPDR Fund (XLV) with a market share of 15%. The Vanguard Health Care ETF (VHT) follows with 12%.

The "moat" or competitive advantage of IYH lies in its broad diversification and the strong brand of iShares. This enables stable performance and a wide investor base. However, some competitors, like XLV, may have a stronger moat due to specific strategies or more cost-effective fee structures.

Overall, IYH offers a solid competitive advantage through its diversification and the support of iShares, but some competitors may excel in certain aspects, such as costs or specific sector engagements.

Healthcare Industry Growth: 6.5% CAGR (2023-2028, estimate) iShares U.S. Healthcare ETF Market Share: Diversified across leading healthcare companies

The iShares U.S. Healthcare ETF (IYH) offers broad diversification within the U.S. healthcare sector. The healthcare sector is expected to grow at an average annual growth rate (CAGR) of 6.5% in the coming years, driven by demographic trends such as an aging population and technological advances in healthcare.

The ETF invests in a variety of companies operating in different areas of healthcare, including pharmaceuticals, biotechnology, medical devices, and healthcare services. This diversification reduces the risk associated with investing in individual stocks while providing access to the growth opportunities of the entire sector.

In addition, investors benefit from the stable demand for healthcare services, which is largely independent of economic cycles. Given these factors, the iShares U.S. Healthcare ETF could be an attractive investment for investors interested in a stable and long-term growth strategy.

Dividend yield: 1.5% (estimated for 2025)
Payout frequency: Quarterly

The iShares U.S. Healthcare ETF (IYH) regularly pays dividends, which are typically distributed quarterly. The dividend yield is usually around 1.5%, which is typical for an ETF in the healthcare sector.

The reliability of the payout is high, as the ETF invests in a variety of stable and established companies in the healthcare sector that are known for their continuous dividend payments. Historically, the ETF has distributed its dividends regularly and without major interruptions.